Time soon advanced by two days.
Negotiations over medical insurance coverage were in full swing, and Star Sea Biotech naturally sent Chen Leyao as planned.
As for Xia Xu, he was neither good at nor fond of such occasions and had never intended to attend. Besides, he had other things to do today.
Early that morning, he had been woken by an excited, impatient phone call from Gu Haiming.
"How is it, Old Master Gu? What's the situation?"
Xia Xu hurried to Star Sea Biotech's research institute.
"It's essentially a success. All that's left is clinical trials."
Gu Haiming came out personally to meet Xia Xu and briskly led him inside. Soon, they entered the biological laboratory he oversaw, which had been partitioned off to occupy an entire floor of the institute.
After an elaborate process of disinfection, sterilization, and changing clothes, Xia Xu saw something that made him slightly uncomfortable inside a transparent glass cage in a sterile room.
A small macaque was confined inside the completely transparent glass cage. It was almost entirely immobilized and anesthetized. There was no wound on its chest, yet blood vessels extended out from it, and a dark red heart the size of an egg beat outside its body.
Without a doubt, this was the "Second Heart" Gu Haiming had proposed just over two months ago.
"The Second Heart was actually relatively simple in terms of genetic technology. It was the organ cultivation that really benefited from Yingke Biotech's laboratory monkeys..."
Gu Haiming gave a detailed account of the experiment and its progress.
Biological and pharmaceutical research had never been professions for the excessively tenderhearted, because neither biotechnology nor pharmaceutical technology could escape clinical trials.
Before clinical trials, the only option was naturally to experiment on animals to control success rates and risks.